Lipocine Inc —— 资产负债表 (NASDAQ:LPCN) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 25.35 M52.48 M37.54 M23 M22.51 M17.01 M 负债总额 10.01 M6.91 M1.91 M2.63 M1.51 M2.53 M 权益总额 15.34 M45.57 M35.63 M20.37 M21 M14.48 M 负债及股东权益总额 25.35 M52.48 M37.54 M23 M22.51 M17.01 M 总债务 5.59 M2.31 M———— 净债务 -14.08 M-42.31 M————

新闻

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13%

美国股市涨跌不一；截至收盘道琼斯工业平均指数下跌0.13%

Lipocine (LPCN) Soars 5.5%: Is Further Upside Left in the Stock?

Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates

Lipocine completes patient visits in phase 3 trial for PPD treatment

H.C. Wainwright上调Lipocine目标股价至15美元，因PPD试验进展

H.C. Wainwright raises Lipocine stock price target to $15 on PPD trial progress

Lipocine completes enrollment in phase 3 trial for PPD treatment

利波辛公司产后抑郁症药物试验在安全性评估后继续进行

Lipocine’s PPD drug trial continues after positive safety review

Lipocine公司在产后抑郁症药物试验中完成80%的入组

Lipocine reaches 80% enrollment in postpartum depression drug trial